Histone deacetylase inhibitors and genomic instability

Grégory Eot-Houllier1, Géraldine Fulcrand, Laura Magnaghi-Jaulin

  • 1Groupe Microtubules et Cycle Cellulaire, Institut de Génétique Humaine, CNRS UPR 1142, rue de la cardonille, 34396 Montpellier cedex 5, France.

Cancer Letters
|July 19, 2008
PubMed

Insights

Histone deacetylase inhibitors (HDACIs) show promise as anticancer drugs by causing genomic instability. This overlooked mechanism involves DNA damage, reactive oxygen species generation, and impaired chromosome segregation, contributing to cancer cell death.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Histone deacetylase inhibitors (HDACIs) are emerging anticancer agents.
  • Their precise mechanisms of action, beyond gene transcription regulation, require further elucidation.
  • HDAC inhibition's impact on genomic stability is a significant, yet understudied, area.

Purpose of the Study:

  • To review the multifaceted effects of HDAC inhibitors on DNA damage and repair pathways.
  • To explore the role of HDAC inhibition in inducing genomic instability.
  • To examine the impact of HDACIs on chromosome segregation during mitosis.

Main Methods:

  • Literature review of studies investigating HDAC inhibitors.
  • Analysis of data on DNA damage and repair mechanisms modulated by HDACIs.
  • Examination of research on mitotic defects and chromosome segregation following HDACI treatment.

Main Results:

  • HDAC inhibition contributes to genomic instability through various mechanisms.
  • HDACIs sensitize cancer cells to genotoxic damage and increase reactive oxygen species production.
  • HDACIs disrupt mitosis, leading to chromosome segregation errors.

Conclusions:

  • Genomic instability is a critical, often overlooked, mechanism contributing to the anticancer effects of HDAC inhibitors.
  • Understanding these effects is crucial for optimizing HDACI-based cancer therapies.
  • HDACIs represent a promising therapeutic strategy by exploiting DNA damage and mitotic disruption pathways.

Related Concept Videos

Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Histone Variants at the Centromere02:30

Histone Variants at the Centromere

Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3 variants are also...
Spreading of Chromatin Modifications02:25

Spreading of Chromatin Modifications

The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer is an enzyme that can...